Short answer
CME Group (CME) filed its Q2 2026 10-Q quarterly report on Jul 24, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $1.7B (up 0.8% year over year) with net income of $1.0B.
Q2 2026 key financials · XBRL
- Revenue
- $1.7B
- +0.8% YoY · −9.2% QoQ
- Net income
- $1.0B
- +1.6% YoY · −12.0% QoQ
- Operating margin
- 64.9%
- EPS (diluted)
- $2.88
- +2.5% YoY · −9.4% QoQ
Source: XBRL data from the CME Group (CME) Q2 2026 10-Q on SEC EDGAR. USD.
CME Group Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,706.2M, up 1% YoY; market data strongest at $238.1M, up 20%
- Operating margin 64.9% vs 66.7% YoY; net income $1,041.8M, up 2%
- Equity indexes best volume performer, up 13%; energy worst, down 13%
- Operating cash flow $2,207.0M; financing cash use higher from increased share repurchases
- Q2 volatility subsided; lower interest-rate and energy volumes amid greater policy certainty and regional stabilization
Risk Factors
- No material changes to risk factors from December 31, 2025 Form 10-K
- Market risk: trading volumes and fee revenue remain sensitive to volatility and economic conditions
- Regulatory risk: extensive derivatives regulation may increase compliance costs and constrain operations
- Operational risk: exchange, clearing, and technology disruptions could impair transaction processing
- Financial risk: clearinghouse exposures and member defaults could create liquidity demands
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CME Group quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.